Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Longboard Pharmaceuticals (LBPH)
NASDAQ:LBPH
RESEARCH TOOLSreports
Longboard Pharmaceuticals (LBPH) Stock Forecast & Price Target
205 Followers
See the Price Targets and Ratings of:
LBPH Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LBPH Stock 12 Month Forecast
Average Price Target
$55.57
▲(80.77% Upside)
| Highest Price Target$90.00 | Average Price Target$55.57 | Lowest Price Target$36.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Cantor Fitzgerald
Reiterated
07/01/24
H.C. Wainwright
Reiterated
06/11/24
B.Riley Financial
Reiterated
06/10/24
Robert W. Baird
Initiated
05/02/24
Guggenheim
$16→$32
Buy
4.10%
Upside
Reiterated
01/02/24
Longboard Pharmaceuticals price target raised to $32 from $16 at GuggenheimLongboard Pharmaceuticals price target raised to $32 from $16 at Guggenheim
―
Evercore ISI
―
Buy
―
Reiterated
07/02/24
We also discussed how we wouldn’t be surprised to see the stock up 50% on a positive DEE update – and it now is. To be clear, we expect more upside ahead) 4 reasons why the broad DEE is important and how it drives our PT up to $80/sh: 1. Unique and differentiated label undoubtedly drives increased adoption, especially in the DEEs – we’re now at $1.5B peak WW sales (which we still think is conservative since there is a clear path to $2B+. Penetration will be closer to Epidiolex vs Fintepla – except at a much higher price…) 2. Which brings us to point 2: with a broad label and no reliance on off-label sales, pricing goes up – we model $80K WAC/$70K net. Notably higher than Epidiolex, but still much lower than FIntepla (from an access POV, keep in mind seizures are a protected class – there’s more pricing power if LBPH wanted to go
Best Analysts Covering Longboard Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy LBPH and Sell After:
1 Month
3 Months
1 Year
Success Rate
17/17 ratings generated profit
Average Return
+158.12%
reiterated a buy rating 22 days ago
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +158.12% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LBPH Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
8
5
8
10
9
Buy
4
0
0
0
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
5
8
10
10
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
LBPH Financial Forecast
LBPH Stock Forecast FAQ
What is LBPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Longboard Pharmaceuticals’s 12-month average price target is $55.57.
What is LBPH’s upside potential, based on the analysts’ average price target?
Longboard Pharmaceuticals has 80.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LBPH a Buy, Sell or Hold?
Longboard Pharmaceuticals has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Longboard Pharmaceuticals’s price target?
The average price target for Longboard Pharmaceuticals is $55.57. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $90.00 ,the lowest forecast is $36.00. The average price target represents 80.77% Increase from the current price of $30.74.
The highest analyst price target is $90.00 ,the lowest forecast is $36.00. The average price target represents 80.77% Increase from the current price of $30.74.
What do analysts say about Longboard Pharmaceuticals?
Longboard Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of LBPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.